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Introductory Chapter: An 
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Non-tubal ectopic pregnancies represent 7–10% of all ectopic pregnancies [1]. 
The incidence is increasing in the past years especially because of assisted reproduc-
tion treatment, particularly IVF, and the high rates of cesarean sections [2].
Non-tubal locations of ectopic pregnancies are cervix, cesarean section scar, 
interstitial portion of the fallopian tube, cornual, ovary, abdominal cavity, and 
broad ligament (Figure 1).
There is a broad spectrum of clinical presentation according to the location of 
the pregnancy. The first symptoms are pelvic pain and vaginal bleeding. In ruptured 
ectopic pregnancies, the patients present with severe abdominal pain, shoulder tip 
pain, nausea, vomiting and dizziness and collapse. However, some women with 
ectopic pregnancy are asymptomatic.
The diagnosis is usually late, because these pregnancies present themselves later 
than tubal pregnancies. Therefore, the risks of maternal morbidity and mortality 
are higher than in tubal ectopic pregnancies.
The management of non-tubal ectopic pregnancy depends on their location. The 
cases of abdominal pregnancy must be individualized and the treatment is different 
from the other sites of ectopic pregnancy. The diagnosis of ovarian pregnancy is 
usually confirmed only during the surgery.
The other sites (cesarean scar, cervical and intersticial pregnancy) follow a 
similar non-surgical protocol.
The classic treatment is surgery; however, it is very aggressive, because in the 
majority of the cases it is necessary to perform a hysterectomy. Several minimally 
invasive techniques have been proposed to avoid the mutilation of the uterus. Some 
of the alternative treatments to avoid surgery are local injection of MTX guided by 
transvaginal ultrasound, systemic medical treatment with methotrexate (MTX), 
and embolization of uterine arteries. There are several case reports in this subject 
but very few original articles. And in the few articles, there is no consensus on the 
best treatment. This book aims to provide the reader with a concise, comprehensive, 
and updated review of the epidemiology, diagnosis, and treatment of non-tubal 
ectopic pregnancy. As there is a lack of consensus on the guideline for the treatment 
of non-tubal ectopic pregnancy, this book intends to fill this gap in the literature, 
compiling the best evidences in the medical literature guiding the reader on choos-
ing the adequate treatment. An overview of each non-tubal ectopic pregnancy site 




It represents 3% of ectopic pregnancies [3]. The sonographic aspect of ovarian 
pregnancy may range from gestational sac containing embryonic structures to 
solid and complex masses similar to those of tubal pregnancy. The major diagnosis 
difficulty is due to the fact that the pregnancy develops in the intimacy of the ovar-
ian parenchyma, losing the reference used in tubal pregnancy, which is to identify 
the ovaries and then look for the pelvic mass. In the case of tubal pregnancy, it 
is imperative to demonstrate the ipsilateral ovary, as well as the adnexal mass, in 
order to decrease the possibility of false-positive diagnosis with ovarian masses. 
Therefore, ultrasound in this eventuality is not specific, once it may confuse ovar-
ian pregnancy with other ovarian tumors. If gestational sac characteristics with 
embryonic structures are observed in the ovary, the diagnosis can be made with 
great precision [4].
Due to the difficulty of confirming the diagnosis noninvasively, most of the 
time, it is made during the intraoperative period. Thus, MTX treatment is used 
sporadically.
3. Intraligamentary abdominal pregnancy
Intraligamentary abdominal pregnancy is a rare form of ectopic pregnancy 
with a reported incidence of less than one in 250 ectopic pregnancies [5]. It usually 
results from the trophoblastic penetration of a tubal pregnancy through the serosa 
into the mesosalpinx, with secondary implantation between the leaves of the broad 
ligament. The placenta usually invades the intraligament space, ovary, uterus, 
omentum, pelvic peritoneum, and adjacent viscera [6].
Signs that may suggest intraligamentary abdominal pregnancy are abnormal 
vaginal bleeding, abdominal pain, painful fetal movements, easy palpation of the 
fetal parts, excessive nausea and vomiting, evidence of intrauterine growth restric-
tion, and oligoamnios. The main antenatal complications include abdominal pain, 
gestational sac rupture with hemorrhage to the peritoneal cavity, vaginal bleeding, 
anomalous presentation, placental insufficiency, and fetal death.
During surgery, the placenta should preferably be removed to reduce the risk of 
peritonitis, abscess, disseminated intravascular coagulation, and persistent tropho-
blastic disease.
Figure 1. 
Principal sites of ectopic pregnancy.
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Intraligamentary pregnancy is a condition of high maternal morbidity and mor-
tality, and a judicious preoperative evaluation and surgical technique are imperative 
for a favorable outcome.
4. Abdominal pregnancy
It constitutes of about 1.5% of ectopic pregnancies [7]. It represents a risk of 
maternal death 7.7 times higher than that of tubal pregnancy and 90 times higher 
than that of intrauterine pregnancy [8]. The blastocyst can be implanted anywhere 
in the abdomen and in the different organs covered by the visceral peritoneum. 
Thus, in abdominal pregnancy, there is the development of the pregnancy in the 
peritoneal cavity. It can be classified into primary or secondary. Primary abdominal 
pregnancy is rare; most are secondary due to tubal rupture or tubal abortion. Few 
fetuses survive in the abdominal cavity and advance beyond the second trimester of 
pregnancy. The diagnostic and therapeutic difficulties are remarkable regardless of 
the location of advanced abdominal pregnancy.
The most frequent ultrasound findings in abdominal pregnancy are as 
follows [9]:
• Uterus separated from fetus (90%)
• Extrauterine placenta (75%)
• Oligoamnium (45%)
• Fetal parts near the abdominal wall (25%)
• Absence of myometrium between fetus/placenta and bladder (15%)
• Anomalous fetal presentation (25–70%)
• Difficulty viewing the placenta (25%)
• Maternal intestinal loops obscuring fetal visualization (25%)
• Fetal anomalies (20–40%)
• Restricted intrauterine growth
• Lack of communication between endocervical canal and gestational sac
The most important signs are overlooked by the examiner because some unusual 
findings do not draw the examiner’s attention to the diagnosis of abdominal preg-
nancy. For example, uterine walls should be visualized even if attention is focused 
entirely on fetal evaluation, as myometrial tissue may not be identified. Given the 
clinical suspicion of abdominal pregnancy (the mother reports feeling the child 
superficially in the abdomen), ultrasound becomes mandatory, but will not always 
be able to confirm the diagnosis accurately. Magnetic resonance imaging can 
confirm the diagnosis.
Fetal survival in abdominal pregnancy is the exception rather than the rule, and 
the live-born fetus is often malformed. As conditions for the concept are precarious, 
they succumb most of the time. In abdominal pregnancy, perinatal mortality ranges 
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from 85 to 95% and maternal mortality is around 3% [10]. Anomalies occur in 
about 1/3 to 1/4 of the fetuses whose viability is possible.
As pregnancy progresses, the placenta develops in any portion or organ of the 
abdominal cavity. We often observe digestive symptoms of subocclusion and exces-
sive abdominal pain to fetal movements. The superficiality of the fetus is clear on 
palpation, as well as the auscultation of the fetal heartbeat. Ultrasound may demon-
strate that the uterus is empty and compressed by the fetus and placenta.
As fetal survival is the exception, many advise against hospitalization to await 
the viability of the fetus. In addition, the risk of life-threatening bleeding is high.
In cases of late diagnosis and with the fetus alive, the follow-up may be to wait 
until the 36th week. In the presence of a dead fetus or living fetus after the 36th 
week, laparotomy is required. Antenatal diagnosis of abdominal pregnancy is 
essential for proper planning of the procedure. Precise placement of the placenta 
can be done more accurately by magnetic resonance imaging (MRI). Preoperative 
care should be individualized for each case according to its severity. Interventional 
radiology can be used with the placement of balloon catheters to prevent signifi-
cant bleeding during surgery. In cases of dead fetus, selective embolization of the 
placental vessels may be performed. In addition, a multiprofessional staff may be 
required to perform insertion of ureteral catheters (double J), bowel preparation or 
transfusion blood reserve. An appreciable volume of blood and catheterized veins 
should be available to allow large volume to be infused rapidly, as well as a central 
venous pressure control and diuresis. In surgery, once the fetus is removed, the 
placenta is observed and, in particular, the site of its implantation. In cases where 
the placenta is attached to large vessels and the diagnosis is only made during sur-
gery, the placenta could be left to prevent massive bleeding and the cord removed 
very close to its implantation site. This attempt should be considered to transfer 
the patient to a tertiary hospital. Evidently, there is a possibility of complications, 
infection, abscess formation, bruising, and intestinal obstruction.
5. Interstitial pregnancy
Interstitial pregnancy is defined as an ectopic pregnancy that is implanted 
in the interstitial portion of the fallopian tube. The interstitial portion is thick, 
0.1–0.7 mm in diameter and 1–2 cm in length, and this part of the tube has a 
greater capacity to expand before rupture than the other segments of the tube 
[11]. Therefore, some cases are asymptomatic until the end of the first trimester of 
gestation and rupture may occur resulting in severe hemorrhage [12]. Because of 
the rich vascular anastomosis of the uterine and the ovarian arteries in this region, 
there may be accentuated hemorrhage. For this reason, early diagnosis is essential to 
reduce morbidity and mortality.
Interstitial pregnancies account for only 2–4% of ectopic pregnancies. However, 
the mortality rate is 2.5% [13]. This is because of the difficulty to confirm the 
diagnosis. Therefore, the late presentation could result in rupture and hemorrhage.
Interstitial pregnancy sometimes is incorrectly confused with cornual. Cornual 
pregnancy refers to a pregnancy in a horn of a bicornuate uterus or a rudimentary 
noncommunicating cavity horn or other Mullerian anomalies. The clinical outcome 
of cornual pregnancy varies greatly, depending on the size and expansile nature of 
the affected horn.
Risk factors for interstitial pregnancy are previous ectopic pregnancy, previous 
ipsilateral or bilateral salpingectomy, conception after in vitro fertilization, and 
history of sexually transmitted disease [14]. The symptoms of interstitial pregnancy 
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are pelvic pain and vaginal bleeding in the first trimester of pregnancy. On physical 
examination, an asymmetric uterine enlargement may be palpable. Signs of acute 
abdomen may occur in interstitial pregnancy rupture with hemoperitoneum; in 
some cases, tachycardia and hypotension may be present.
The following are the ultrasound features for the diagnosis of interstitial preg-
nancy are (Figure 2):
• Interstitial line (echogenic line between the gestational sac in the interstitial 
region and the endometrial cavity)
• Eccentrically located gestational sac and myometrial thickness less than 5 mm
It is important to point out that some viable intrauterine pregnancies are visual-
ized by ultrasound in its early stages, in one of the lateral angles of the uterine 
cavity, medial to the uterotubal junction. This situation usually evolves to a viable 
intrauterine pregnancy and in some cases the incorrect diagnosis could lead to an 
unnecessary pregnancy interruption.
Classical treatments for interstitial pregnancy are resection of the interstitial 
portion of the tube or hysterectomy. If the diagnosis is made before rupture, mini-
mally invasive surgery and nonsurgical treatment options can be used. Conservative 
options include methotrexate administration (local and systemic), expectant 
management, and minimally invasive surgical techniques that include resection of 
the involved interstitial portion of the tube and preserving the uterine architecture. 
The potential advantage of clinical treatment is to avoid a surgical scar on the uterus 
and the risks associated to surgery.
Expectant management that has been practiced based on the natural course of 
many early EPs is a self-limiting process [16]. The patients selection for this man-
agement are hemodynamically stable patients, beta-hCG ≤ 2000 mUI/ml, decline 
Figure 2. 
Interstitial ectopic pregnancy: Presence of an eccentric gestational sac with myometrial tissue that surrounds the 
gestational sac with a thickness of 2 mm and the interstitial line [15].
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of the titers of beta-hCG in an interval of 24/48 h, and interstitial pregnancy 
mass ≤ 3.5 cm and without fetal cardiac activity.
Systemic methotrexate treatment was used for the first time in an interstitial 
pregnancy. In 1982, Tanaka et al. [17] successfully treated an interstitial pregnancy 
using methotrexate. Ectopic interstitial pregnancies without embryonic cardiac 
activity and beta-hCG ≤ 5000 mUI/ml should be treated using a single dose of 
MTX 50 mg/m2 IM. Cases with beta-hCG > 5000 mUI/ml should be treated with a 
protocol of multiple doses of MTX. On the other hand, cases with embryonic heart 
activity should be treated with transvaginal administration of MTX under sono-
graphic guidance.
6. Cervical pregnancy
Cervical ectopic pregnancy is defined by the implantation and development of 
the conceptus in the cervical canal. Among all ectopic pregnancies, the cervical 
pregnancy is the rarest, representing about 0.4% of cases [1]. It is accompanied 
by high morbidity and mortality, which can lead to severe hemorrhage, due to the 
rich vascularization of the cervix and a small amount of muscle fibers. The etiol-
ogy is not well established; however, some predisposing factors were related, such 
as previous uterine curettages and cesarean section, Asherman syndrome, history 
of uterine and cervical surgeries, and in vitro fertilization. The diagnosis is made 
through history and physical examination and confirmed by ultrasound. Patients 
with menstrual delay and positive pregnancy tests may be asymptomatic, complain 
of vaginal bleeding, or even have severe vaginal bleeding. On vaginal examination, 
the cervix will be enlarged and congested, with painful tumoration. In addition, 
however, complaints and physical examination are often nonspecific, making clini-
cal diagnosis difficult.
Early diagnosis made by ultrasound contributes to the success of conservative 
therapies. Ultrasound findings include empty uterine cavity; endometrial decidu-
ous reaction; hourglass-shaped uterus; enlarged cervical canal; gestational sac 
within the canal, with or without heartbeat; placental tissue surrounding the gesta-
tional sac; and closed internal os of the cervix. These findings can also be visualized 
in MRI with more accuracy (Figure 3).
If the clinical condition is unstable due to the hemorrhagic situation, it is valid 
to use the Foley catheter into the cervix insufflating from 30 to 100 ml while the 
patient is stabilized and then to evaluate the need for a hysterectomy.
With the development of conservative treatment protocols, the need for hys-
terectomies has decreased from 89.5% before 1987 to 21% in 1994. Conservative 
treatment options can be categorized as tamponade, which is performed with 
intracervical balloon after curettage; cerclage to reduce cervical artery blood flow 
associated with manual intrauterine cervical aspiration; reduced blood supply 
through embolization or uterine artery ligation; excision of trophoblastic tissue by 
hysteroscopic resection; intra-amniotic feticide, by local injection of methotrexate; 
and systemic chemotherapy with intramuscular methotrexate.
In cases of embryo without heartbeat with high beta-hCG titers, multiple dose 
of systemic MTX treatment is the preferred therapeutic option. When the embryo 
presents heartbeat, local treatment with MTX is indicated. Elito et al. [18] pub-
lished a series of eight cases of cervical pregnancy with live embryo treated with 
transvaginal US-guided gestational sac puncture and MTX injection (1 mg/kg). All 
patients were successfully treated. The initial beta-hCG ranged from 3013 to 71,199 
mIU/mL. Only one case evolved to infection. There was no need for further inter-
ventions in this case series. The time interval for beta-hCG titers to be negative was 
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2–12 weeks. The period for the disappearance of the image of the ectopic pregnancy 
assessed by ultrasound was 3–14 weeks. Two patients had subsequent intrauterine 
pregnancies. The authors concluded that conservative treatment of cervical ectopic 
pregnancy with live embryos treated with transvaginal US-guided puncture and 
MTX injection is effective and avoids other mutilating interventions.
7. Cesarean scar pregnancy
Pregnancy in cesarean section scar is the rarest form of ectopic pregnancy. 
From the first case described in 1978 [19] to 2001, there were only 19 reported cases 
[20]. In 2006, there were 155 cases and in 2011 the number of cases described in 
the literature was 751, which shows a rapid increase in the incidence of this type 
of pregnancy. The estimated incidence is from 1 in 1800 to 1 in 2216 pregnancies, 
with a rate of 6.1% of all ectopic pregnancies in women with a history of previous 
cesarean section [1].
The basis of the pathophysiology is the invasion of the blastocyst in the myome-
trium through minimal communication between the anterior cesarean section scar 
and the endometrial cavity.
Risk factors are previous cesarean sections, short time between cesarean section 
and current pregnancy, IVF treatment, and retroverted uterus, which may lead to 
greater cesarean section scar dehiscence increasing the chance of implantation of 
the gestational sac in this region.
The cesarean scar ectopic pregnancy tends to behave more aggressively because 
of the risk of uterine rupture and bleeding in the first and second trimesters of 
pregnancy.
Transvaginal ultrasound allows early diagnosis of the disease before these tragic 
outcomes and allows conservative treatment rather than mutilating surgeries such 
as hysterectomy and then preserving fertility. It also allows differential diagnosis 
with ongoing abortion, molar pregnancy, and ectopic cervical pregnancy.
The diagnosis can be made by ultrasonography (Figure 4) and magnetic reso-
nance imaging (Figure 5).
Transvaginal ultrasound findings for cesarean scar pregnancy include empty 
uterine cavity, decidual reaction, trophoblast located at the site of previous cesarean 
scar, and absence of healthy myometrium between the bladder and gestational sac.
Figure 3. 
Magnetic resonance image showing cervical pregnancy, hourglass-shaped uterus, empty uterine cavity, and 
cervix with heterogeneous mass inside. (author image file).
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There are two types of ectopic pregnancy in cesarean scar section: endogenous 
and exogenous. In the endogenous type, gestational sac implantation occurs in 
the cesarean section scar, with the development of pregnancy toward the uterine 
cavity. The exogenous type occurs with deeper implantation of the gestational sac 
in the cesarean scar, and as the pregnancy develops in the direction of the bladder, it 
increases the risk of rupture and hemorrhage in the first trimester of pregnancy.
The relationship between the gestational sac of a cesarean scar pregnancy and 
the endometrial line is defined as crossover sign (COS). In this sonographic sign, a 
straight line was drawn connecting the internal cervical os and the uterine fundus 
through the endometrium (endometrial line). The gestational sac was identified 
and its diameter, perpendicular to the endometrial line, was traced. Patients were 
categorized according to the relationship between the endometrial line and the 
diameter of the gestational sac into two groups: (1) COS-1, in which the gestational 
sac was implanted within the cesarean scar, and at least two-thirds of the diameter of 
the gestational sac was above the endometrial line, toward the anterior uterine wall; 
and (2) COS-2, in which the gestational sac was implanted within the cesarean scar, 
and less than two-thirds of the gestational sac was above the endometrial line [21] 
(Figure 6).
Figure 4. 
Cesarean scar pregnancy in the isthmic region with the presence of gestational sac with embryo. (author image 
file).
Figure 5. 
MRI of the uterus demonstrating an empty uterus, an empty cervical canal, the gestational sac being located in 
the anterior part of the isthmic portion of the uterus with a diminished myometrial layer, and a discontinuity 
in the anterior wall of the uterus.
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This crossover sign may help to determine whether a cesarean scar pregnancy 
will progress to rupture in the first trimester (COS-1), or in a COS-2 case, the 
pregnancy could continue running the risk of placenta accreta and cesarean hyster-
ectomy [21].
Approaches are divided into surgical and nonsurgical treatment. Surgical treat-
ment may include uterine curettage or hysterectomy and uterine artery emboliza-
tion. Nonsurgical treatment may be expectant or medical treatment with systemic 
or local methotrexate.
There is still no consensus on the best mode of treatment in case of ectopic 
pregnancy in cesarean scar section.
Surgical intervention is performed in the presence of important bleeding and, 
under these circumstances, if possible, a uterine artery embolization attempted 
before curettage or hysterectomy.
Dilatation and curettage with subsequent intrauterine Foley catheter insertion 
may be an option due to the simplicity. However, the risk of this treatment is the 
hemorrhage and the necessity of secondary hysterectomy. This treatment should 
only be used in selected cases.
Excision by hysteroscopy is another option. During the procedure, the pelvic 
ultrasound could help to avoid complications.
Excision by laparotomy or laparoscopy could be attempted. These procedures 
usually are performed if local MTX treatment failed or after uterine rupture.
Hysterectomy is usually performed when other treatments failed and to con-
trol the bleeding (Figure 7). This procedure is not the first line for the majority of 
gynecologists.
When the patient presents a cesarean scar pregnancy COS-2 or endogenous 
type and it is a viable pregnancy, the patient should be advised about the risks 
of continuing with the pregnancy. The late diagnosis of cesarean scar pregnancy 
evolves to a placenta accreta. The risks of continuing the pregnancy are hemor-
rhage (13% in first and second trimesters, and 39% in third trimester), uterine 
rupture (9.9% in first and second trimesters, and 10.2% in third trimester), 
placenta accreta 75%, and hysterectomy (15.2% in first and second trimesters, 
and 60.6% in the third trimester) [22]. The physician should discuss these risks 
and advise the patient. A deep reflection of the situation is required before 
taking the decision to keep or not the pregnancy, once the couple usually already 
has one child. When the decision is to continue with the pregnancy, some criteria 
Figure 6. 
Crossover sign representing COS 1, in which the gestational sac was implanted within the Cesarean scar, and 
at least two-thirds of the diameter of the gestational sac was above the endometrial line, towards the anterior 
uterine wall; and COS-2, in which the gestational sac was implanted within the Cesarean scar, and less than 
two-thirds of the gestational sac was above the endometrial line [21].
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should be evaluated. In cases that have crossover sign (COS-1) or exogenous type 
and the magnetic resonance shows myometrium less than 5 mm, the pregnancy 
should be interrupted. In the other situation COS-2 or endogenous type and 
myometrium thickness > 5 mm, if the patient opts to continue with the preg-
nancy, they should be advised about the risk of placenta accreta and cesarean 
hysterectomy and should be assisted in a hospital with interventionist radiology 
and neonatal intensive care.
Systemic methotrexate treatment is not effective in cases where the embryo has 
heartbeat. This treatment should be avoided in this condition because it delays a 
more effective treatment.
In cesarean scar pregnancy when the embryo/fetus has heartbeat, local metho-
trexate (1 mg/kg) treatment guided by transvaginal ultrasound should be the first 
option [23] (Figures 8 and 9). The current scientific evidences demonstrate that 
local treatment with MTX brings best results. This type of treatment is broadly used 
because it is not only effective but also simple and low cost.
In cases where the embryo/fetus has no heartbeat, it is important to check the 
titers of beta-hCG in an interval of 24/48 hours. If the levels were low and declin-
ing, the best approach is the expectant management. However, if the titers were 
high and increasing, the patient should be submitted to the systemic treatment with 
MTX. If the levels of beta-hCG are low (less than 5.000 mUI/ml), a single dose 
of MTX 50 mg/m2 (same treatment of tubal pregnancy) is recommended. On the 
other hand, if the levels are higher (>5.000 mUI/ml), a protocol of multiple doses 
of MTX (1 mg/kg) on days 1, 3, 5, and 7 and folinic acid (0.1 mg/kg) on days 2, 4, 6, 
and 8 is recommended.
The MTX treatment is an outpatient follow-up with weekly examinations of 
β-hCG until resolution. During outpatient follow-up, ultrasound is not routinely 
performed and should only be repeated when β-hCG reaches a negative value 
3 months in a row. Other than that the ultrasound should be repeated during the 
treatment in any case of complication suspected. In general, after 3–6 months, 
the image of the ectopic pregnancy disappears, and at this point, it is recom-
mended to perform hysterosalpingography and hysteroscopy for a better evalua-
tion of the uterine cavity, as well as appropriate reproductive planning for these 
patients [1].
In cases where the resolution takes a long period, other treatments could be 
offered, such as gestational sac aspiration under ultrasound or hysteroscopy to 
remove the gestational tissue with vascular coagulation of the implantation site.
Figure 7. 
Case of cesarean scar pregnancy evolved to hemorrhage and the patient was submitted to hysterectomy.
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In cases where local methotrexate treatment fails, uterine artery embolization 
should be considered [24], or laparoscopic or laparotomic cesarean scar pregnancy 
wedge resection with subsequent surgical correction of the cesarean section scar.
Birch et al. [25] in a systematic review about treatments for cesarean scar preg-
nancy showed that uterine artery embolization (UAE) combined with D&C had 
good results, because it presented a low risk of heavy bleeding and hysterectomy.
Figure 8. 
The patient in the lithotomy position. A 22-gauge, 15 cm Wallace needle was inserted via vaginal route under 
transvaginal ultrasound guidance.
Figure 9. 




The UAE procedure can be performed under spinal anesthesia and conscious seda-
tion with standard antibiotic prophylaxis. After asepsis of groin area, the right or left 
common femoral artery is cannulated via the Seldinger technique, introducer 5F, and 
the procedure continues such as in the uterine fibroid embolization, with catheteriza-
tion of the left uterine artery and subsequently the right uterine artery. Methotrexate 
is injected transarterially prior to the embolization with occluding microparticles, 
always larger than 500 μ to avoid paradoxical embolization to the ovary [26] 
(Figure 10). Despite arterial occlusion, the risk of severe bleeding is non-negligible 
because of gradual restoration of the normal circulation within approximately 
3 weeks. The dilation and curettage with suction or vacuum aspiration 6–8 hours after 
intra-arterial chemoembolization reduce the incidence of bleeding [25].
Figure 11. 
The management protocol of cesarean scar pregnancy.
Figure 10. 
Bilateral uterine angiography before and after uterine artery embolization (a) uterine arteries were enlarged 
by means of hypervascular infusion of methotrexate before uterine artery embolization, (b) unilateral 
occlusion was successfully performed, (c) bilateral arterial occlusion was confirmed after the uterine artery 
embolization and no extravasation was observed [26].
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There is a lack of consensus on the guideline for the treatment of cesarean scar 
pregnancy and several options of treatment are proposed in the literature (isolated 
or combined) [27]. Therefore, the author prepared a protocol to manage cesarean 
scar pregnancy based on his experience and the scientific evidences collected until 
now (Figure 11).
8. Nonsurgical treatment in non-tubal pregnancies
Management in cases of interstitial, cervical, and cesarean scar pregnancy 
should always be individualized. Nonsurgical treatment has emerged as an 
important alternative for these situations, avoiding surgeries that compromise the 
reproductive future. When the embryo has heartbeat, USTV-guided local treatment 
with MTX injection into the gestational sac at a dose of 1 mg/kg is the first-line 
treatment. When beta-hCG titers are greater than 5000 mIU/ml, the local treatment 
is complemented with the systemic multiple-dose protocol starting the day after 
puncture. Systemic treatment with MTX is performed in cases where the embryo 
has no heartbeat. The medical treatment will depend on the initial beta-hCG titer. 
For titers below 5000 mIU/ml, a single dose of MTX 50 mg/m2 IM is recommended. 
On the other hand, if beta-hCG titers are greater than 5000 mIU/ml, a multiple 
dose MTX protocol is recommended. The MTX dose is 1 mg/kg IM on days 1, 3, 5, 
and 7, alternating with folinic acid at the dose of 0.1 mg/kg IM on days 2, 4, 6, and 8 
(Figure 12).
9. Final considerations
Non-tubal pregnancy is a challenge for obstetricians due to the maternal 
morbidity and mortality. The incidence is increasing and the physicians should be 
aware of this situation. The early diagnosis by ultrasound is essential for a minimal 
invasive treatment avoiding fertility loss. There are several options for the treatment 
and no consensus in medical literature. In this introductory chapter, surgical and 
nonsurgical approaches as well as guidelines have been presented for the treatment 
of non-tubal pregnancy based on current scientific evidence.
Figure 12. 
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